Serum S100B protein and cutaneous malignant melanoma stage: A prospective study;Proteine S100B serique et stade du melanome cutane: Etude prospective

Annales de Dermatologie et de Venereologie

Volumn 127, Issue 1, 2000, Pages 56-59

  Brouard, M ^a   Quillien, V ^b   Ollivier, I ^a   Lesimple, T ^b   Adamski, H ^a   Chevrant Breton, J ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100; PROTEIN S100B; TUMOR MARKER; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; NERVE GROWTH FACTOR; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ADULT; AGED; BLOOD; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; ROC CURVE; SKIN TUMOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; FOLLOW-UP STUDIES; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; S100 PROTEINS; SKIN NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034043496     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schäfer B, Heizmann C. The S100 family of EF-hand calcium-binding proteins: functions and pathology. TIBS 1996;21:134-40.
2. Zimmer D, Cornwall E, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
3. Böni R, Burg G, Doguoglu A, Ilg E, Schäfer B, Müller B, Heizmann C. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 1997;137:39-43.
4. 2+-binding proteins S100A6 and S100B in primary cutaneous melanoma. J Cutan Pathol 1997;24:76-80.
5. Ilg E, Schäfer B, Heizmann C. Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 1996;68:325-32.
6. Kizawa K, Tsuchimoto S, Hashimoto K, Uchiwa H. Gene expression of mouse S100A3, a cysteine-rich calcium-binding protein, in developing hair follicle. J Invest Dermatol 1998;111:879-86.
7. Weiss S, Langloss J, Enzinger F. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983;49:299-308.
8. Gaynor R, Irie R, Morton D, Herschman H. S100 protein is present in cultured human malignant melanomas. Nature 1980;286:400-1.
9. Baudier J, Delphin C, Grunwald D, Khochbin S, Lawrence JJ. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci USA 1992;89: 11627-31.
10. 2+-dependent manner. Protein Science 1998;7:794-8.
11. Terryberry J, Thor G, Peter J. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol Aging 1998;19:205-16.
12. Jonsson H, Johnsson P, Alling C, Westaby S, Blomquist S. Significance of serum S100 release after coronary artery bypass grafting. Ann Thorac Surg 1998;65:1639-44.
13. Gaynor R, Irie R, Morton D, Herschman HR, Jones P, Cochran A. S100 protein: a marker for human malignant melanomas? Lancet 1981;i:869-71.
14. Abraha HD, Fuller LC, Du Vivier AWP, Higgins EM, Sherwood RA. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 1997;137:381-5.
15. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmüller D. Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 1995;31A : 924-8.
16. Henze G, Dummer R, Joller-Jemelka H, Böni R, Burg G. Serum S100 - a marker for disease monitoring in metastatic melanoma. Dermatology 1997;194:208-12.
17. Schultz ES, Diepgen TL, Von Den Driesch P. Clinical and prognostic relevance of serum S-100β protein in malignant melanoma. Br J Dermatol 1998;138:426-30.
18. Tofani A, Cioffi R, Sciuto R, Rea S, Festa A, Di Filippo F, et al. S-100 and NSE as serum markers in melanoma. Acta Oncol 1997;36:761-4.
19. Von Schoultz E, Hansson LO, Djureen E, Hansson J, Kärnell R, Nilsson B, et al. Prognostic value of serum analyses of S-100β protein in malignant melanoma. Melanoma Research 1996;6:133-7.
20. Grob JJ. Mélanomes cutanés. In: Saurat JH, Grosshans E, Laugier P, Lachapelle JM, eds. Dermatologie et maladies sexuellement transmissibles. Paris: Massen, 1999:600-9.
21. Morin V, Morin JF, Mercier M, Moineau MP, Codet JP. Les courbes ROC en biologie médicale. Immunoanal Biol Spec 1998;13:279-86.